Animal models of asthma: utility and limitations

• Published in: Journal of asthma and allergy Vol. 10; pp. 293 - 301
• Main Authors: Aun, Marcelo, Bonamichi-Santos, Rafael, Arantes-Costa, Fernanda Magalhães, Kalil, Jorge, Giavina-Bianchi, Pedro
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.01.2017; Taylor & Francis Ltd; Dove Medical Press
• Subjects: Airway hyperresponsiveness; Allergen; Allergens; Allergies; Analysis; Anaphylaxis; Animal experimentation; Animal models; Antigens; Asthma; Challenge; Clinical trials; Disease; Drug therapy; Genetic engineering; Immunoglobulins; Immunology; Inflammation; Inhalation; Insects; Internal medicine; Laboratory animals; Ovalbumin; Pets; Physiology; Respiratory tract; Review; Rodents; Sensitization; Smooth muscle; Species; Trachea; Brazil; airway hyperresponsiveness; allergen; challenge; animal models; asthma; sensitization
• ISSN: 1178-6965; 1178-6965
• DOI: 10.2147/JAA.S121092

Clinical studies in asthma are not able to clear up all aspects of disease pathophysiology. Animal models have been developed to better understand these mechanisms and to evaluate both safety and efficacy of therapies before starting clinical trials. Several species of animals have been used in experimental models of asthma, such as , rats, guinea pigs, cats, dogs, pigs, primates and equines. However, the most common species studied in the last two decades is mice, particularly BALB/c. Animal models of asthma try to mimic the pathophysiology of human disease. They classically include two phases: sensitization and challenge. Sensitization is traditionally performed by intraperitoneal and subcutaneous routes, but intranasal instillation of allergens has been increasingly used because human asthma is induced by inhalation of allergens. Challenges with allergens are performed through aerosol, intranasal or intratracheal instillation. However, few studies have compared different routes of sensitization and challenge. The causative allergen is another important issue in developing a good animal model. Despite being more traditional and leading to intense inflammation, ovalbumin has been replaced by aeroallergens, such as house dust mites, to use the allergens that cause human disease. Finally, researchers should define outcomes to be evaluated, such as serum-specific antibodies, airway hyperresponsiveness, inflammation and remodeling. The present review analyzes the animal models of asthma, assessing differences between species, allergens and routes of allergen administration.